LU74749A1 - - Google Patents

Info

Publication number
LU74749A1
LU74749A1 LU74749A LU74749A LU74749A1 LU 74749 A1 LU74749 A1 LU 74749A1 LU 74749 A LU74749 A LU 74749A LU 74749 A LU74749 A LU 74749A LU 74749 A1 LU74749 A1 LU 74749A1
Authority
LU
Luxembourg
Application number
LU74749A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed filed Critical
Publication of LU74749A1 publication Critical patent/LU74749A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02Preparation
    • C07D503/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU74749A 1975-04-14 1976-04-12 LU74749A1 (en])

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GB3967175 1975-09-27

Publications (1)

Publication Number Publication Date
LU74749A1 true LU74749A1 (en]) 1976-11-11

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74749A LU74749A1 (en]) 1975-04-14 1976-04-12

Country Status (22)

Country Link
JP (1) JPS51127093A (en])
AR (1) AR208773A1 (en])
AT (1) AT342199B (en])
AU (1) AU497577B2 (en])
CA (1) CA1074802A (en])
CH (1) CH602742A5 (en])
DE (1) DE2616088A1 (en])
DK (1) DK144066C (en])
ES (1) ES446468A1 (en])
FI (1) FI760946A7 (en])
FR (1) FR2336130A1 (en])
GR (1) GR58256B (en])
HU (1) HU175444B (en])
IE (1) IE42666B1 (en])
IL (1) IL49279A (en])
LU (1) LU74749A1 (en])
MX (1) MX3453E (en])
NL (1) NL7603840A (en])
NO (1) NO761241L (en])
PT (1) PT64897B (en])
SE (1) SE427037B (en])
YU (1) YU69476A (en])

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5359690A (en) * 1976-09-09 1978-05-29 Glaxo Lab Ltd Production of novel betaa lactam
DE2747599A1 (de) * 1976-10-25 1978-04-27 Glaxo Lab Ltd Clavulansaeurederivate, verfahren zu deren herstellung und diese enthaltende zusammensetzungen
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
DK144066B (da) 1981-11-30
AR208773A1 (es) 1977-02-28
ATA215576A (de) 1977-07-15
FR2336130B1 (en]) 1979-06-22
NL7603840A (nl) 1976-10-18
AU497577B2 (en) 1978-12-21
JPS51127093A (en) 1976-11-05
IL49279A0 (en) 1976-06-30
GR58256B (en) 1977-09-15
PT64897A (en) 1976-04-01
SE427037B (sv) 1983-02-28
CA1074802A (en) 1980-04-01
DK156576A (da) 1976-10-15
FR2336130A1 (fr) 1977-07-22
NO761241L (en]) 1976-10-15
DK144066C (da) 1982-05-10
AT342199B (de) 1978-03-28
HU175444B (hu) 1980-08-28
PT64897B (en) 1977-08-18
MX3453E (es) 1980-12-03
DE2616088A1 (de) 1976-10-28
IE42666L (en) 1976-10-14
IL49279A (en) 1979-05-31
FI760946A7 (en]) 1976-10-15
IE42666B1 (en) 1980-09-24
YU69476A (en) 1982-05-31
CH602742A5 (en]) 1978-07-31
SE7604287L (sv) 1976-10-15
ES446468A1 (es) 1977-11-01
AU1302076A (en) 1977-10-20

Similar Documents

Publication Publication Date Title
JPS54681B2 (en])
FR2326998B1 (en])
FR2336130B1 (en])
JPS51122962U (en])
JPS5189638A (en])
FR2302674B3 (en])
FI761126A7 (en])
JPS51109117U (en])
JPS5267132U (en])
JPS5250803U (en])
JPS5239942U (en])
JPS5267394U (en])
JPS5199644U (en])
JPS5285379U (en])
JPS5276792U (en])
JPS5120008U (en])
JPS51160303U (en])
CH604651A5 (en])
CH603853A5 (en])
CH591949A5 (en])
CH601931A5 (en])
CH599460A5 (en])
CH604769A5 (en])
CH591910A5 (en])
CH591705A5 (en])